|
Volumn 52, Issue 16, 2009, Pages 5262-5268
|
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,3 METHYLENEDIOXY 6 METHOXY 9 BROMOMETHYLPHENANTHRENE;
2,3 METHYLENEDIOXY 6 METHOXY 9 HYDROXYLMETHYLPHENANTHRENE;
2,3 METHYLENEDIOXY 6 METHOXYPHENANTHRENE 9 CARBOXYLIC ACID METHYL ESTER;
ANTINEOPLASTIC AGENT;
CYTOTOXIC AGENT;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 3' AMINOMETHYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 3' AMINOPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 3' HYDROXYLMETHYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 3' N BUTYLOXYCARBONYLAMINOMETHYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 3' N BUTYLOXYCARBONYLAMINOPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 3' PIPERIDONE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' AMINOMETHYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' AMINOPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' CYANOPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' HYDROXYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' METHANESULFONYLAMINOMETHYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' N BUTYLOXYCARBONYLAMINOMETHYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' N BUTYLOXYCARBONYLAMINOPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' PIPERIDONE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' PIPERIDONE 3' CARBOXYLIC ACID METHYL ESTER;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL) 4' TRIFLUOROMETHYLPIPERIDINE;
N (2,3 METHYLENEDIOXY 6 METHOXYPHENANTHR 9 YLMETHYL)PIPERIDINE 3' CARBOXYLIC ACID METHYL ESTER;
PHENANTHRENE DERIVATIVE;
PROTEIN KINASE B;
TYLOPHORINE;
TYLOPHORINE DERIVATIVE;
UNCLASSIFIED DRUG;
YXM 35;
YXM 41;
YXM 43;
YXM 44;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CONTROLLED STUDY;
CYTOPATHOGENIC EFFECT;
DRUG DESIGN;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ASSAY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
SIGNAL TRANSDUCTION;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
ALKALOIDS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
INDOLES;
INDOLIZINES;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
NF-KAPPA B;
PHENANTHRENES;
PHENANTHROLINES;
PIPERIDINES;
PROTO-ONCOGENE PROTEINS C-AKT;
SIGNAL TRANSDUCTION;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 69049104190
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm9009263 Document Type: Article |
Times cited : (45)
|
References (11)
|